More than 600 million people globally suffer from low back pain, with projections suggesting this number will rise to 800 million by 2030. A recent review indicates that only one in ten non-interventional treatments, which include various pharmacological and non-pharmacological approaches, have demonstrated effectiveness beyond placebo. This highlights a significant gap in effective management for what is the leading cause of disability worldwide. The study, led by Aidan Cashin, analyzed numerous placebo-controlled trials to assess treatment outcomes for chronic and acute low back pain, ultimately finding only minimal analgesic effects from most treatments.
Only one in 10 non-interventional treatments is effective in treating back pain, showing that most treatments provide minimal benefits beyond placebo.
The analysis reveals that, while there are many non-surgical options available, effectiveness remains a critical concern in managing lower back pain treatments.
Collection
[
|
...
]